✦ LIBER ✦

[90Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer : Long-term results of a phase 2 clinical trial

✍ Scribed by Fabienne Iten; Beat Muller; Christian Schindler; Helmut Rasch; Christoph Rochlitz; Daniel Oertli; Helmut R. Maecke; Jan Muller-Brand; Martin A. Walter

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 550 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24272

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views